Sign In

Chris Mason

Professor of Cell & Gene Therapy, University College London

Chris Mason is a highly experienced clinician-scientist and entrepreneur in the field of cell and gene therapy. Here are some key details about him:

Professional Background

Chris Mason has over 30 years of experience in cell and gene therapy, spanning various aspects including:

  • Research and development
  • Clinical medicine
  • Manufacturing
  • Commercialization1

Current Roles

  • Director on the Board of Directors at Papillon Therapeutics14
  • Full Professor of Cell and Gene Therapy at University College London1
  • Senior Editor of the journals 'Cell and Gene Therapy Insights' and 'Regenerative Medicine'1

Entrepreneurial Experience

Chris Mason is a serial entrepreneur with several notable positions:

  • Founder and CEO of Sun Vectors1
  • Co-founder and Non-Executive Director of OriBiotech12
  • Founder and former Chief Scientific Officer at Avrobio (NASDAQ: AVRO)12

Industry Involvement

  • Instrumental in founding the Alliance for Regenerative Medicine (ARM), where he currently serves as a Board Director1
  • Board Director for several companies, including Krystal Biotech1

Qualifications

Chris Mason holds the following qualifications:

  • MD (Medical Doctor)
  • PhD
  • FRCS (Fellow of the Royal College of Surgeons)
  • FMedSci (Fellow of the Academy of Medical Sciences)23

His LinkedIn username is profchrismason, as mentioned in the query.

Related Questions

What are Chris Mason's key achievements at Avrobio?
How did Chris Mason contribute to the founding of the Alliance for Regenerative Medicine?
What is Chris Mason's role at OriBiotech?
Can you provide more details about Chris Mason's work at University College London?
What are the main projects Chris Mason is involved in at Papillon Therapeutics?
Chris Mason
Chris Mason, photo 1
Chris Mason, photo 2
Add to my network

Location

San Diego, California, United States